Niagen Bioscience (NASDAQ:NAGE) Downgraded to Buy Rating by Wall Street Zen
Niagen Bioscience (NASDAQ:NAGE – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday. NAGE has been the topic of a number of other research reports. Roth Capital reissued a “buy” rating and set a $23.00 price target […]
Niagen Bioscience (NASDAQ:NAGE – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday. NAGE has been the topic of a number of other research reports. Roth Capital reissued a “buy” rating and set a $23.00 price target […]
